Novel composition method of using the same for the treatment of lyme disease

A method of treating Lyme disease caused by Borrelia Species in a host, comprising:

• preparing a composition and administering the composition to the host, wherein the composition consists of:
• a vitamin which is at least one of Vitamin C, Vitamin B complex and Vitamin D3;
• a small fatty acid signaling molecule which is Cis-2-decenoic acid;
• an essential amino acid which is at least one of L-Lysin, Aminocaproic acid and Tranexamic acid;
• a flavonoid which is at least one of Luteolin, Apigenin, Baicalein, Fisetin, Kaempherol, Myricetin and Quercetin 3D;
• a plant extract which is at least one of Oleuropein, Teasel Root Extract, Oregano Oil, Kelp, Monolaurin, Nordihydroguaiaretic acid, Fucoinad, Olein, Rosmarinic acid, Morin, Aronia, Rottlerin, Malvidin, Grape seed extract (OPC) and Piceatannol;
• and
• a mineral which is Kelp (Iodine).

A method, comprising:

• making a mixture at a specific concentration to treat a Lyme disease at the acute stage and the chronic stage wherein the mixture is consists of a vitamin, which is at least one of a Vitamin C, Vitamin B complex and Vitamin D3, a small fatty acid signaling molecule which is Cis-2-decenoic acid, an essential amino acid which is at least one of a L-Lysin, Aminocaproic acid and Tranexamic acid, a flavonoid, which is at least one of a Luteolin, Apigenin, Baicalein, Fisetin, Kaempherol, Myricetin and Quercetin 3D, a plant extract, which is at least one of a Oleuropein, Teasel Root Extract, Oregano Oil, Kelp, Monolaurin, Nordihydroguaiaretic acid, Fucoinad, Olein, Rosmarinic acid, Morin, Aronia, Rottlerin, Malvidin, Grape seed extract (OPC) and Piceatannol and a mineral which is a Kelp (Iodine);
• in human and other mammals;
• and
• administering the mixture in a specific form of delivery for treating and preventing for a specific duration.

A method of treating Lyme disease caused by Borrelia Species in a host, comprising administering to the host a composition consisting of:

• a vitamin which is at least one of Vitamin C, Vitamin B complex and Vitamin D3;
• a small fatty acid signaling molecule which is Cis-2-decenoic acid;
• an essential amino acid which is at least one of L-Lysin, Aminocaproic acid and Tranexamic acid;
• a flavonoid which is at least one of Luteolin, Apigenin, Baicalein, Fisetin, Kaempherol, Myricetin and Quercetin 3D;
• a plant extract which is at least one of Oleuropein, Teasel Root Extract, Oregano Oil, Kelp, Monolaurin, Nordihydroguaiaretic acid, Fucoinad, Olein, Rosmarinic acid, Morin, Aronia, Rottlerin, Malvidin, Grape seed extract (OPC) and Piceatannol;
• and
• a mineral which is a Kelp (Iodine).

A method of treating Lyme disease caused by Borrelia Species in a host, comprising preparing a composition and administering the composition to the host, wherein the composition consists of:

• a vitamin which is at least one of Vitamin C, Vitamin B complex and Vitamin D3;
• a small fatty acid signaling molecule which is Cis-2-decenoic acid;
• an essential amino acid which is at least one of L-Lysin, Aminocaproic acid and Tranexamic acid;
• a flavonoid which is at least one of Luteolin, Apigenin, Baicalein, Fisetin, Kaempherol, Myricetin and Quercetin 3D;
• a plant extract which is at least one of Oleuropein, Teasel Root Extract, Oregano Oil, Kelp, Monolaurin, Nordihydroguaiaretic acid, Fucoinad, Olein, Rosmarinic acid, Morin, Aronia, Rottlerin, Malvidin, Grape seed extract (OPC) and Piceatannol;
• a mineral which is a Kelp (Iodine);
• and
• a pharmaceutically acceptable excipient.